Physician profile
Juliet Clutter
NPI 1033751201
$1,364.02
in general payments reported to CMS, 2019-2025
13 companies · $296 in 2025
The $296 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $697 · 2022: $250 · 2023: $17.64 · 2024: $104 · 2025: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $417.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $417.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $417.55 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $286.38 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $249.19 | 2021 | |
| Dexcom, INC. | $127.19 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $84.17 | 2024-2025 | Jardiance |
| Organon LLC | $49.47 | 2022 | |
| Pfizer INC. | $48.57 | 2022-2024 | |
| Neurocrine Biosciences, INC. | $25.85 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.00 | 2021 | |
| Glaxosmithkline, LLC. | $16.65 | 2025 | Shingrix |
| Amgen INC. | $15.68 | 2025 | Repatha, Otezla |
| Janssen Pharmaceuticals, INC | $14.04 | 2021 | |
| Sanofi Pasteur INC. | $11.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juliet Clutter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.